Historic Gene Editing Drug Approved in UK; Chinese Tech Stocks Sink; Apple Lags on Modem Chip; Amazon to Sell Cars Online; Walmart Sees Slowing Holiday Sales
-
CRISPR Therapeutics and Vertex Pharmaceuticals make history with first CRISPR-based drug approval in UK for sickle cell and beta-thalassemia treatment.
-
Chinese tech stocks tumble after Biden-Xi meeting fails to ease economic tensions; Alibaba disappoints with results.
-
Apple likely to miss 2025 target for in-house iPhone modem chip, boosting Qualcomm.
-
Amazon partners with Hyundai to launch online auto sales in U.S. in 2024, disrupting market.
-
Walmart beats earnings but signals slowing consumer spending ahead of holidays, moderating sales growth.